Rethinking funding priorities in mental health research

Roberto Lewis-Fernández; Mary Jane Rotheram-Borus; Virginia Trotter Betts; Lisa Greenman; Susan M Essock; Javier I Escobar; Deanna Barch; Michael F Hogan; Patricia A Areán; Benjamin G Druss; Ralph J DiClemente; Thomas H McGlashan; Dilip V Jeste; Enola K Proctor; Pedro Ruiz; A John Rush; Glorisa J Canino; Carl C Bell; Renata Henry; Portia Iversen

doi:10.1192/bjp.bp.115.179895

Rethinking funding priorities in mental health research

Br J Psychiatry. 2016 Jun;208(6):507-9. doi: 10.1192/bjp.bp.115.179895.

Authors

Roberto Lewis-Fernández¹, Mary Jane Rotheram-Borus¹, Virginia Trotter Betts¹, Lisa Greenman¹, Susan M Essock¹, Javier I Escobar¹, Deanna Barch¹, Michael F Hogan¹, Patricia A Areán¹, Benjamin G Druss¹, Ralph J DiClemente¹, Thomas H McGlashan¹, Dilip V Jeste¹, Enola K Proctor¹, Pedro Ruiz¹, A John Rush¹, Glorisa J Canino¹, Carl C Bell¹, Renata Henry¹, Portia Iversen¹

Affiliation

¹ Roberto Lewis-Fernández, MD, Columbia University Medical Center, and New York State Center of Excellence for Cultural Competence, and Hispanic Treatment Program, at the New York State Psychiatric Institute, New York, USA; Mary Jane Rotheram-Borus, PhD, Department of Psychiatry and Biobehavioral Sciences, Semel Institute, University of California at Los Angeles, Los Angeles, California, USA; Virginia Trotter Betts, MSN, JD, RN, HealthFutures, Inc., Nashville, Tennessee, USA; Lisa Greenman, JD, Attorney At Law, Washington, DC, USA; Susan M. Essock, PhD, Columbia University Medical Center, New York, USA; Javier I. Escobar, MD, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA; Deanna Barch, PhD, Washington University in St Louis, St Louis, Missouri, USA; Michael F. Hogan, PhD, Dartmouth (Geisinger) Medical School, Case Western Reserve Medical School, and New York University Medical School, and Hogan Health Solutions, New York, USA; Patricia A. Areán, PhD, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA; Benjamin G. Druss, MD, MPH, Ralph J. DiClemente, PhD, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA; Thomas H. McGlashan, MD, Yale University School of Medicine, and Connecticut Mental Health Center, New Haven, Connecticut, USA; Dilip V. Jeste, MD, Sam and Rose Stein Institute for Research on Aging, University of California San Diego, San Diego, California, USA; Enola K. Proctor, PhD, Brown School of Social Work, and Center for Mental Health Services Research, Washington University in St Louis, St Louis, Missouri, USA; Pedro Ruiz, MD, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, Florida, USA; A. John Rush, MD, Duke-National University of Singapore, and Duke Medical School, Santa Fe, New Mexico, USA; Glorisa J. Canino, PhD, Behavioral Sciences Research Institute, and Department of Pediatrics, University of Pu

PMID: 27251688
DOI: 10.1192/bjp.bp.115.179895

Abstract

Mental health research funding priorities in high-income countries must balance longer-term investment in identifying neurobiological mechanisms of disease with shorter-term funding of novel prevention and treatment strategies to alleviate the current burden of mental illness. Prioritising one area of science over others risks reduced returns on the entire scientific portfolio.

Publication types

Editorial

MeSH terms

Biomedical Research / economics*
Humans
Mental Health / economics*